![]()
|
|
||||||||
J. Biol. Chem., Vol. 260, Issue 29, 15477-15481, Dec, 1985
HU Affolter and T Reisine
The ability of corticotropin releasing factor (CRF) to stimulate
adrenocorticotropin (ACTH) synthesis in corticotrophs was assessed by
measuring total cell content of ACTH and the levels of proopiomelanocortin
(POMC) mRNA in a cloned tumor cell line of the mouse anterior pituitary
(AtT-20/D16-16). CRF treatment caused a time- dependent increase in POMC
mRNA levels (measured using a hybridization technique) as well as elevating
total ACTH content in AtT-20 cells. The increase in POMC mRNA levels
preceded changes in ACTH content and slowly returned toward control levels
after CRF withdrawal. The rise in POMC mRNA levels following CRF
stimulation appeared to be specific since beta-actin mRNA levels were not
affected by CRF treatment. Both 8- bromo-cAMP and phorbol ester increased
POMC mRNA levels in AtT-20 cells, suggesting that CRF may act through
different protein kinases to regulate the POMC gene. CRF appears to
activate the POMC gene since treatment of the AtT-20 cells with the peptide
increased the levels of an RNA species in the nuclei having the expected
molecular weight of the transcript of the POMC gene. The results indicate
that continued exposure of corticotrophs to CRF induces long term increases
in the ACTH synthetic capacity of those cells.
Corticotropin releasing factor increases proopiomelanocortin messenger RNA in mouse anterior pituitary tumor cells
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. Murakami, S. Takeuchi, T. Kudo, S. Sutou, and S. Takahashi Corticotropin-releasing hormone or dexamethasone regulates rat proopiomelanocortin transcription through Tpit/Pitx-responsive element in its promoter J. Endocrinol., May 1, 2007; 193(2): 279 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Luque, M. D. Gahete, U. Hochgeschwender, and R. D. Kineman Evidence that endogenous SST inhibits ACTH and ghrelin expression by independent pathways. Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E395 - E403. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Aoki, Y. Iwasaki, M. Katahira, Y. Oiso, and H. Saito Regulation of the Rat Proopiomelanocortin Gene Expression in AtT-20 Cells. I: Effects of the Common Secretagogues Endocrinology, May 1, 1997; 138(5): 1923 - 1929. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saito, K. Maruyama, H. Kawano, K. Hagino-Yamagishi, K. Kawamura, T. C. Saido, and S. Kawashima Molecular Cloning and Characterization of a Novel Form of Neuropeptide Gene as a Developmentally Regulated Molecule J. Biol. Chem., June 28, 1996; 271(26): 15615 - 15622. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fremeau Jr, J. Lundblad, D. Pritchett, J. Wilcox, and J. Roberts Regulation of pro-opiomelanocortin gene transcription in individual cell nuclei Science, December 5, 1986; 234(4781): 1265 - 1269. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |